Jpmorgan Chase & CO Pulse Biosciences, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 9,556 shares of PLSE stock, worth $165,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,556
Previous 8,309
15.01%
Holding current value
$165,414
Previous $153,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PLSE
# of Institutions
88Shares Held
5.55MCall Options Held
76.1KPut Options Held
60.8K-
Black Rock Inc. New York, NY1.15MShares$19.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA843KShares$14.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC778KShares$13.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA466KShares$8.06 Million0.0% of portfolio
-
State Street Corp Boston, MA419KShares$7.26 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $643M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...